Pataday, Patanase, Opatanol (olopatadine) is a small molecule pharmaceutical. Olopatadine was first approved as Pataday on 1996-12-18. It is used to treat allergic conjunctivitis in the USA. It has been approved in Europe to treat allergic conjunctivitis. Olopatadine hydrochloride's patents are valid until 2032-05-19 (FDA).
|Drug Class||Tricyclic histaminic-H1 receptor antagonists, loratadine derivatives|